Global Immunodiagnostics Market Overview:
Immunodiagnostics is the branch of in vitro diagnostics that deals with the diagnosis of several diseases on the basis of antigen antibody reaction. Its a primary means for diagnosing infectious disease, chronic diseases such as cancer and cardiovascular diseases, autoimmunity diseases, and endocrinology among others. The significant advancement in the immunodiagnostics technologies have enhanced the ability to target the areas to diagnose disease progression. The growth in development has improved the diagnosis of complex diseases. Some of the players profiled in the study are Abbott Laboratories (United States), Biomérieux SA (France), Danaher Corporation (United States), Thermo Fisher Scientific (United States), F. Hoffmann-La Roche Ltd. (Switzerland), OraSure Technologies Inc. (United States), Quest Diagnostics Inc. (United States), Siemens AG (Germany), Sysmex Corp. (Japan) and Tecan Group Ltd. (Switzerland).
On the basis of geography, the market of Immunodiagnostics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Enzyme-Linked Immunosorbent Assay will boost the Immunodiagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Clinical laboratories will boost the Immunodiagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- Rise in incidences of infectious diseases (HIV, STI, hepatitis B, and others), cardiovascular diseases, cancer, gastrointestinal, and other chronic diseases
- Technological advancement in diagnosis kits, assays and analysers
- Inadequate reimbursements hindering the growth of the market
- Increase in awareness of the preventive health measures among the patients and medical professionals
- Lack of awareness regarding immunodiagnostics
Global immunodiagnostics market is is highly competitive and consists of a limited number of vendors who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant growth opportunities for the market in forecast years.
Target Audience:New Entrants/Investors, Analysts and Strategic Business Planners, Immunodiagnostics Provider, Government Regulatory, Research Organizations and End Users
Major Objectives Focused through this Study To define, describe, and forecast the Global Immunodiagnostics market on the basis of product [Reagents, Instruments and Software & Services] , application [Oncology and Endocrinology, Hepatitis and Retrovirus Testing, Infectious Disease Testing and GI Stool Testing], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Immunodiagnostics market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Immunodiagnostics industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Immunodiagnostics market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.